Assanto , Giovanni Manfredi, et al. “Impact of Sars-CoV-2 Prophylaxis With Tixagevimab-Cilgavimab in High-Risk Patients With B-Cell Malignancies: A Single-Center Retrospective Study”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 15, no. 1, Oct. 2023, p. e2023061, doi:10.4084/MJHID.2023.061.